article thumbnail

An Additional Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The CCP Hybrid Choice program is unique in that it offers patients the choice to join, or to remain in the traditional practice, as before. The CCP Hybrid Choice program is unique in that it offers patients the choice to join, or to remain in the traditional practice, as before. The patient decides what’s right for them.

article thumbnail

Patients with Epilepsy and Special Considerations in Women with Dr. Brittany Chapman

Louisville Lectures

After, she reviews special considerations for women with epilepsy. Chapman is ABPN board certified in Neurology with special qualification in Sleep Medicine and Epilepsy. Disclaimers ©2015 LouisvilleLectures.org She then details the work up for seizures along with treatment. of Neurology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

Just like in the case of other medical specialties , disruptive innovations will have a huge impact on how dentistry will be practiced and how patients will take care of themselves in the future. For patients, it promises more accurate care and better outcomes. How about having a teledentist consultation?

Patients 126
article thumbnail

Hypertension with Dr. Nina Vasavada

Louisville Lectures

Nina Vasavada presents Hypertension by first discussing a general approach to ambulatory patients with elevated blood pressure. She then presents primary versus secondary hypertension, and ends her discussion on hypertension management in special populations. Disclaimers ©2015 LouisvilleLectures.org Vasavada, M.D.

article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

The California-based firm, Second Sight , the German company, Retina Implant AG, and the French venture, Pixium Vision were the forerunners of the field, developing implantable visual prosthetics to restore vision to patients who are blind as a result of the rare condition of retinitis pigmentosa. That must have been truly amazing!

article thumbnail

Episode 354: Antiracism in Medicine – Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting

The Clinical Problem Solvers

Michelle Ogunwole, MD, PhD, an internist and social epidemiologist who specializes in the care of women with chronic medical conditions and racial disparities in maternal health outcomes, and Dr. Caroline Sloan, MD, a general internist whose research focuses on how financial considerations are imbued into medical decision-making. Zakaria, S.,

article thumbnail

A Historic Day in Drug Development: FDA Approves Amylyx’s Drug to Treat ALS, Demonstrating FDA’s Application of Appropriate Flexibility in Rare Diseases

FDA Law Blog

Valentine — On September 29, 2022, FDA approved Amylyx’s NDA for its drug, Relyvrio (sodium phenylbutyrate/taurursodiol), for treatment of patients with amyotrophic lateral sclerosis (ALS) (see FDA announcement here ). This is evidence of FDA’s embrace of patient-focused drug development. By Frank J. Sasinowski & James E.